Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Central nervous system salicylate.

J R Reed, P A Palmisano

    Clinical Toxicology
    |January 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Serum unbound salicylate levels better reflect poisoning severity than total levels. This study in dogs suggests unbound levels correlate with cerebrospinal fluid salicylate, offering a more accurate clinical assessment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Use of the Skin Cancer Quality of Life Impact Tool (SCQOLIT) - a feasibility study in non-melanoma skin cancer.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2019
    Same author

    Developing a dedicated dermatology service for allogeneic bone marrow transplant recipients.

    The British journal of dermatology·2017
    Same author

    Investigation of the cutaneous response to recall antigen in humans in vivo.

    Clinical and experimental immunology·2013
    Same author

    Sympathetic ophthalmitis.

    The Journal of the Oklahoma State Medical Association·2010
    Same author

    Relative impact of CD4+CD25+ regulatory T cells and tacrolimus on inhibition of T-cell proliferation in patients with atopic dermatitis.

    The British journal of dermatology·2005
    Same author

    The immunomodulatory effects of regulatory T cells: implications for immune regulation in the skin.

    The British journal of dermatology·2005
    Same journal

    Chronic central nervous system toxicity of the chickling pea (Lathyrus sativus).

    Clinical toxicology·1981
    Same journal

    Brain energy metabolism in mice exposed to oxygen at 1 atmosphere absolute.

    Clinical toxicology·1981
    Same journal

    Toxicity of some essential plant oils. Clinical and experimental study.

    Clinical toxicology·1981
    Same journal

    Carbon disulfide neuropathy in rats. A morphological and ultrastructural study of degeneration and regeneration.

    Clinical toxicology·1981
    Same journal

    Regional differences in brain-soluble acetylcholinesterase and its molecular forms after acute poisoning by isoflurophate in rats.

    Clinical toxicology·1981
    Same journal

    Industrial neuropathy due to n-hexane. Clinical and morphological findings in three cases.

    Clinical toxicology·1981
    See all related articles

    Area of Science:

    • Pharmacology
    • Toxicology
    • Clinical Chemistry

    Background:

    • Clinical salicylate toxicity often poorly correlates with total serum salicylate levels.
    • Serum salicylate levels can be misleading due to altered volume of distribution (Vd).
    • Factors like protein binding and pH-dependent ionization affect Vd and salicylate distribution.

    Purpose of the Study:

    • To investigate serum unbound salicylate levels as a more accurate marker for salicylate poisoning severity.
    • To compare serum unbound salicylate levels with cerebrospinal fluid (CSF) salicylate levels.
    • To evaluate the influence of altered protein binding and pH on salicylate distribution.

    Main Methods:

    • The study was conducted in dogs.
    • Serum unbound salicylate levels were measured.

    Related Experiment Videos

  • Cerebrospinal fluid (CSF) salicylate levels were assessed.
  • Changes in serum protein binding and pH were induced and their effects observed.
  • Main Results:

    • Serum unbound salicylate levels closely reflected CSF salicylate levels during changes in serum protein binding.
    • Serum unbound salicylate levels did not accurately reflect CSF salicylate levels when serum pH decreased (acidosis).
    • Total serum salicylate levels decreased significantly with altered protein binding or acidosis, masking increased CSF salicylate.

    Conclusions:

    • Serum unbound salicylate measurements appear more reliable than total serum salicylate levels for assessing salicylate poisoning severity.
    • Unbound salicylate levels offer a potential alternative to impractical CSF measurements.
    • Further research is needed to fully understand the utility of unbound salicylate levels in various clinical scenarios, particularly concerning acidosis.